aTyr Pharma, Inc. (LIFE)
NASDAQ: LIFE · IEX Real-Time Price · USD
1.950
-0.050 (-2.50%)
Mar 28, 2024, 3:59 PM EDT - Market closed

aTyr Pharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 23.67, with a low estimate of 16 and a high estimate of 35. The average target predicts an increase of 1,113.85% from the current stock price of 1.95.

Analyst Consensus: Buy
Target Low Average Median High
Price $16 $23.67 $20 $35
Change +720.51% +1113.8% +925.64% +1694.9%

Analyst Ratings

The average analyst rating for aTyr Pharma stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 222221
Buy 222222
Hold 111111
Sell 000000
Strong Sell 000000
Total 555554

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Buy
Maintains
$19$16
Buy Maintains $19$16 +720.51% Mar 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,694.87% Mar 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,694.87% Feb 21, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,694.87% Sep 21, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,694.87% Sep 14, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
7.28M
from 353.00K
Increased by 1,962.32%
Revenue Next Year
9.55M
from 7.28M
Increased by 31.20%
EPS This Year
-0.87
from -0.94
EPS Next Year
-0.97
from -0.87
Year 2019202020212022202320242025202620272028
Revenue
422.00K10.46M-10.39M353.00K7.28M9.55M94.68M200.18M432.67M
Revenue Growth
-2,377.49%---96.60%1,962.32%31.20%891.27%111.44%116.14%
EPS
-7.03-1.77-1.77-1.60-0.94-0.87-0.97-0.180.882.88
EPS Growth
---------227.25%
No. Analysts -----77666
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 26.3M 25.6M 171.9M 298.8M 717.6M
Avg 7.3M 9.6M 94.7M 200.2M 432.7M
Low n/a n/a 26.4M 68.9M 195.0M

Revenue Growth

Revenue Growth 20242025202620272028
High
7,336.3%
252.3%
1,699.7%
215.6%
258.5%
Avg
1,962.3%
31.2%
891.3%
111.4%
116.1%
Low - -
176.9%
-27.2%
-2.6%

EPS Forecast

EPS 20242025202620272028
High -0.59 -0.91 0.84 2.06 5.16
Avg -0.87 -0.97 -0.18 0.88 2.88
Low -0.97 -1.01 -0.81 -0.18 1.23

EPS Growth

EPS Growth 20242025202620272028
High - - - -
486.0%
Avg - - - -
227.2%
Low - - - -
39.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.